β-Alanyl-L-histidine dipeptide, highly concentrated in fast-twitch skeletal muscle (~20–40 mmol/kg dry weight) and olfactory bulb. Intramuscular roles: proton buffer (pKa 6.83 — ideal for pH-drop during high-intensity contraction), reactive carbonyl / metal ion chelator, and pH-independent Ca²⁺ sensitiser in myofibrils. Orally, intact carnosine is rapidly cleaved by serum carnosinase (CN1/CNDP1) and tissue carnosinase (CN2) to β-alanine + histidine within minutes of absorption. Therefore oral carnosine itself is a poor way to raise muscle carnosine — oral β-alanine is the rate-limiting precursor and the evidence-based route.
Half-Life & Elimination Curve (PO: 1m)
Plasma (PO)t½ Decay (1m)
0×t½0h100%(0.115 mg/L)
1×t½1m50%(57.7 µg/L)
2×t½2m25%(28.8 µg/L)
3×t½4m12.5%(14.4 µg/L)
4×t½5m6.3%(7.21 µg/L)
5×t½6m3.1%(3.61 µg/L)
Elimination t½1m (PO)
Rate Constant (ke)34.7 h⁻¹
Time to Peak (Tmax)5m
Est. Peak (Cmax)0.115 mg/L
Clearance (CL)728 L/h
97% Washout (5×t½)6m
Dosing Guidelines
Oral (PO): Typical 1 g (Range: 0.5–2 g)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 5% · Volume of Distribution (Vd): 21 L · Absorption (ka): 2 h⁻¹ (t½ka ≈ 21m) [PMID 37081019]
β-Alanine (synergistic): β-Alanine is the rate-limiting precursor for endogenous muscle carnosine synthesis — the evidence-based way to raise intramuscular carnosine.